Merck COVID-19 pill success slams Moderna shares, shakes up health care sector
October 02, 2021 at 23:05 PM EDT
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
